Asunto(s)
Antihelmínticos/farmacología , Dirofilaria immitis/aislamiento & purificación , Dirofilariasis/diagnóstico , Dirofilariasis/epidemiología , Parasitemia/diagnóstico , Parasitemia/epidemiología , Animales , Arsenamida/farmacología , Arsenicales/farmacología , Dirofilariasis/tratamiento farmacológico , Dirofilariasis/parasitología , Perros , Monitoreo Epidemiológico , Ivermectina/farmacología , Microscopía , Parasitemia/tratamiento farmacológico , Parasitemia/parasitología , Federación de Rusia/epidemiología , Triazinas/farmacologíaRESUMEN
Effects of a variety of compounds on spontaneous contractile activity of whole, intact, adult canine heartworms (HW), which had been maintained in culture, were evaluated to improve understanding of the pharmacological sensitivities of this parasitic nematode. Acetylcholine, pilocarpine, imidazole, levamisole, and DL-tetramisole caused spastic paralysis. Gamma-aminobutyrate (GABA), the GABA-mimetic muscimol, the GABA amino transferase inhibitor 3-mercaptopropionic acid, fenthion, ketamine, levodopa, and salinomycin caused flaccid paralysis. Atropine and monensin had inhibitory effects. Neostigmine, the neuromuscular blocking agents decamethonium, succinylcholine, and D-tubocurarine, and the aminergic agents epinephrine, norepinephrine, and serotonin had little or no effect on contractile activity. Thiacetarsamide had a nonreversible, slow onset, inhibitory effect on contractile activity. Occurrence of spastic or flaccid paralysis was not correlated with gender or culture age and was never associated with the same compound. Submaximal stimulatory or inhibitory responses paralleled the type of maximal responses (spastic or flaccid paralysis) for most compounds. Concentration variations producing maximal effects suggested considerable variation in individual preparation sensitivity, which did not appear to involve cuticle defects or time in culture. Difference in gender sensitivity was noted only for levamisole, which caused greater stimulation of contractile activity in males than in females.
Asunto(s)
Dirofilaria immitis/efectos de los fármacos , Dirofilariasis/parasitología , Enfermedades de los Perros/parasitología , Animales , Arsenamida/farmacología , Dirofilaria immitis/aislamiento & purificación , Dirofilaria immitis/fisiología , Perros , Inhibidores Enzimáticos/farmacología , Femenino , Filaricidas/farmacología , Ionóforos/farmacología , Masculino , Contracción Muscular/efectos de los fármacos , Neurotransmisores/farmacología , Pruebas de Sensibilidad Parasitaria/veterinaria , Fármacos del Sistema Nervioso Periférico/farmacología , Factores Sexuales , Factores de TiempoRESUMEN
OBJECTIVE: To test the effect of thiacetarsamide and melarsomine on vascular responses in isolated rings of pulmonary artery from heartworm-infected dogs. ANIMALS: 18 heartworm-infected dogs. PROCEDURE: Isolated rings of pulmonary artery from heartworm-infected dogs were randomly treated with thiacetarsamide (30 micrograms/ml) or melarsomine dihydrochloride (30 micrograms/ml) for 30 minutes; untreated rings from the same dog served as control. Cumulative dose-response relations to norepinephrine, nitroglycerin, and methacholine were determined. RESULTS: Norepinephrine-induced constriction was not altered by treatment with either thiacetarsamide or melarsomine. Treatment with thiacetarsamide depressed nitroglycerin-induced relaxation, compared with values for untreated control rings and rings treated with melarsomine. Treatment of rings with thiacetarsamide or melarsomine depressed methacholine-induced relaxation, compared with values for untreated rings. Histologic examination of rings indicated that treatment with thiacetarsamide or melarsomine resulted in loss of endothelial cells. CONCLUSION: Endothelial cell loss as a direct drug effect may be responsible for impaired endothelium-dependent relaxation in pulmonary artery from heartworm-infected dogs. Thiacetarsamide appears to have additional effects on vascular smooth muscle, which may explain why fewer complications are observed in dogs treated with melarsomine. CLINICAL RELEVANCE: Melarsomine may be a safer drug than thiacetarsamide and could be a better treatment for dogs with heartworm infection.
Asunto(s)
Arsenamida/farmacología , Arsenicales/farmacología , Dirofilariasis/fisiopatología , Enfermedades de los Perros/fisiopatología , Filaricidas/farmacología , Arteria Pulmonar/efectos de los fármacos , Triazinas/farmacología , Animales , Arsenamida/uso terapéutico , Arsenicales/uso terapéutico , Dirofilaria immitis/aislamiento & purificación , Dirofilariasis/tratamiento farmacológico , Dirofilariasis/patología , Enfermedades de los Perros/tratamiento farmacológico , Enfermedades de los Perros/patología , Perros , Relación Dosis-Respuesta a Droga , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/parasitología , Endotelio Vascular/patología , Femenino , Filaricidas/uso terapéutico , Técnicas In Vitro , Masculino , Cloruro de Metacolina/farmacología , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/parasitología , Músculo Liso Vascular/fisiología , Nitroglicerina/farmacología , Norepinefrina/farmacología , Arteria Pulmonar/parasitología , Arteria Pulmonar/fisiología , Distribución Aleatoria , Triazinas/uso terapéutico , Vasoconstrictores/farmacología , Vasodilatadores/farmacologíaRESUMEN
Little information is available on the primary pharmacological effects of thiacetarsamide on mammalian systems, particularly on blood vessels. The effects of thiacetarsamide on arterial responses was studied in isolated rings from canine pulmonary artery. Vessels were exposed to thiacetarsamide and dose-response relationships were applied to methacholine and nitroglycerin. To rule out non-specific effects of antihelmintics, the effects of two other antifilarial drugs, diethylcarbamazine and ivermectin, were also tested. Thiacetarsamide significantly depressed relaxation of canine pulmonary artery to both methacholine and nitroglycerin, and significantly enhanced constriction to norepinephrine. Neither diethylcarbamazine nor ivermectin altered vascular response. These direct effects of thiacetarsamide on arterial responsiveness may be responsible, in part, for acute pulmonary complications observed in dogs infected with Dirofilaria immitis after adulticide treatment.
Asunto(s)
Arsenamida/farmacología , Filaricidas/farmacología , Músculo Liso Vascular/efectos de los fármacos , Arteria Pulmonar/efectos de los fármacos , Animales , Antihelmínticos/farmacología , Arsenamida/uso terapéutico , Dietilcarbamazina/farmacología , Dirofilariasis/tratamiento farmacológico , Enfermedades de los Perros/tratamiento farmacológico , Perros , Relación Dosis-Respuesta a Droga , Filaricidas/uso terapéutico , Técnicas In Vitro , Ivermectina/farmacología , Cloruro de Metacolina/farmacología , Relajación Muscular/efectos de los fármacos , Nitroglicerina/farmacología , Parasimpaticomiméticos/farmacología , Distribución Aleatoria , Vasodilatadores/farmacologíaRESUMEN
To implement a new macrofilaricide, treatment of heartworm infection or disease in dogs was checked in all the clinical situations ie from subclinical to severe disease. After preliminary toxicity and efficacy models on experimentally infected dogs, in addition, to the reference posology (2.5 mg of melarsomine (RM 340)/kg twice, 24 h apart by deep IM injection) a more practical program for vet practitioners was suggested (2.2 mg/kg twice, 3 h apart) using modelization of the pharmacokinetic data. The two treatments were equivalent as shown on models with experimental infection of dogs, critical tests on naturally infected dogs and clinical trials in veterinary practice. We advise using specific and well adapted therapeutic programs for each of the clinical classes (class 1: subclinical, class 2: moderate, class 3: severe). The safety margin is respectively x 3 or x 2.5 in contrast with thiacetarsamide which, being hepatotoxic, has no safety margin, and sometimes is nephrotoxic at the recommended dose. RM 340 is fully effective on D immitis adults (even on young ones of 7 months old) and L5 immatures (4 months old) when thiacetarsamide is poorly effective on 7 months or ineffective on 4-month-old parasites. Clinical trials in veterinary practice showed that the programs are well adapted to many clinical situations. The product is effective, relatively safe and easy to handle by IM injection. Preliminary results show its possible use as tactical treatment (2.2 mg/kg twice, 3 h apart) twice a year in mid August and December-January to prevent heartworm disease.
Asunto(s)
Arsenamida/uso terapéutico , Arsenicales/uso terapéutico , Dirofilariasis/veterinaria , Enfermedades de los Perros/tratamiento farmacológico , Filaricidas/uso terapéutico , Triazinas/uso terapéutico , Animales , Arsenamida/farmacocinética , Arsenamida/farmacología , Arsenicales/farmacocinética , Arsenicales/farmacología , Dirofilaria immitis/efectos de los fármacos , Dirofilariasis/tratamiento farmacológico , Perros , Filaricidas/farmacocinética , Filaricidas/farmacología , Microfilarias/efectos de los fármacos , Triazinas/farmacocinética , Triazinas/farmacologíaRESUMEN
Platelet aggregation and release, platelet number, mean platelet volume, antithrombin-III activity, and fibrinogen concentration were evaluated in heartworm-negative and heartworm-infected dogs at baseline and on days 3, 10, and 21 after treatment with thiacetarsamide. Platelet reactivity was enhanced in a group of dogs naturally infected with Dirofilaria immitis, compared with 2 groups of heartworm-negative dogs, but platelet reactivity was not further enhanced after treatment with thiacetarsamide. A significant decrease in antithrombin-III activity was detected 21 days after treatment. The platelets from a group of laboratory Beagles implanted with 50 adult D immitis displayed enhanced reactivity 6 months after implantation, but by 18 months, platelet reactivity had returned to near, or less than, baseline. Platelet reactivity was enhanced after thiacetarsamide treatment in this group. Thiacetarsamide-associated changes were not observed in platelet number or size; antithrombin-III activity decreased, but the change was not significant. Fibrinogen concentration was increased significantly (P less than 0.05) on day 10. Enhanced adenosine diphosphate (ADP)-induced platelet aggregation was observed on days 3, 10, and 21 after treatment in heartworm-negative dogs. This change was not observed in 6 control Beagles not treated with thiacetarsamide. Although antithrombin-III activity was decreased on day 3 and fibrinogen concentration was increased on day 10, paralleling changes observed in the heartworm-infected dogs, the changes were not statistically significant. In this study, thiacetarsamide was procagulatory in heartworm-negative dogs and may be an important contributing factor to the thromboembolism observed with adulticidal therapy.
Asunto(s)
Arsenamida/uso terapéutico , Plaquetas/fisiología , Dirofilariasis/veterinaria , Enfermedades de los Perros/sangre , Animales , Antitrombina III/análisis , Arsenamida/farmacología , Plaquetas/citología , Plaquetas/efectos de los fármacos , Dirofilariasis/sangre , Dirofilariasis/tratamiento farmacológico , Enfermedades de los Perros/tratamiento farmacológico , Perros , Fibrinógeno/análisis , Agregación Plaquetaria , Recuento de Plaquetas/veterinaria , Serotonina/metabolismoRESUMEN
Clinical laboratory evaluations were performed in 7 beagles for 12 months following experimental infection with Dirofilaria immitis and for 14 months following adulticide and microfilaricide treatment. Few abnormalities were detected. A mild basophilia and thrombocytopenia developed late during the year of infection and after arsenical treatment there were transient increases in eosinophils, SGPT, and SAP. Coagulation and blood gas studies were normal. The minimal changes were attributed to either: (1) the one year infection with 50 infective larvae was an insufficient insult or (2) an idiosyncrasy in the host-parasite relationship is required in order to produce marked alterations in clinical laboratory evaluations.